The pooled prevalence of BRCA1 mutation among hereditary breast and/ or ovarian cancer was 12% (95% CI: 4–21%) (Fig. 3b) [4, 5, 7, 17, 19–25]. This evidence concerns the gene BRCA1 and ovarian cancer.